[Safety and efficacy of LK565--a new polymer ultrasound contrast medium]. / Untersuchungen zur Sicherheit und Effizienz von LK565--einem neuen Polymer-Ultraschallkontrastmittel.

We tested a newly developed ultrasound contrast agent (LK565) from poly-aspartic acid (PAA; particle size 3 microns; particle content: air) in 15 healthy male probands (20-38 years) in doses of 10, 30 and 100 mg intravenously. One day and immediately before the study a routine laboratory test, an ECG and an EEG were performed. The EEG was continued through the complete time period that the ultrasound contrast lasted, i.e., up to one hour after the injection. All probands were followed clinically for 24 hours when the routine laboratory and the ECG were repeated. All subjects tolerated the contrast agent well. There were no changes in either the EEG or in the ECGs performed throughout the study. There were no significant laboratory changes except for a small and transient increase in the neutrophil count in five probands receiving the highest dose. All injections with 10 mg led to a significant improvement in the color Doppler signal. All injections with 30 and 100 mg led to a very strong echo contrast lasting for 5 to 12 minutes in the harmonic B-mode. Using the latter, fragments of intramyocardial coronaries could be visualized. The tested ultrasound polymer contrast agent was safe, well tolerated and efficient in this acute study.

Transthoracic and transesophageal echocardiography to diagnose ventricular septal rupture: importance of right heart infarction.

BACKGROUND: Rapid and accurate diagnosis of ventricular septal rupture (VSR) remains difficult, and the monitoring of hemodynamic deterioration is a prerequisite for the institution of adequate therapy. The timing of surgical repair is a matter of controversy. METHODS: Transthoracic, transesophageal, color Doppler, and contrast echocardiography were evaluated in 17 patients with VSR in whom the diagnosis was confirmed by catheterization, surgery, or necropsy. RESULTS: Routine transthoracic echocardiography visualized VSR in four out of 17 patients and, with additional views, in 12 out of 17 patients. Color Doppler echocardiography identified the rupture in 15 out of 16, and contrast echocardiography in 11 out of 11 patients. VSR was identified using transesophageal echocardiography in six out of nine patients, and using color Doppler and contrast echocardiography in all patients. Eight out of 10 patients who developed right heart myocardial infarction (RMI) died, whereas all patients without RMI survived (P = 0.0070). Similarly, eight out of 10 patients with shock died, whereas all patients without survived (P = 0.0070). Shock occurred more often in patients with RMI (eight out of 10) than in patients without (two out of six). All patients with both RMI and shock died, whereas those without both conditions survived (P = 0.0002). CONCLUSION: Modern echocardiography is the method of choice in the diagnosis of VSR. Right ventricular function should be evaluated in patients with VSR because patients with RMI are at high risk of hemodynamic deterioration, with poor outcome. RMI, visible as abnormal wall motion, was identified better with transesophageal than with transthoracic echocardiography.

Diagnosis of papillary muscle rupture after acute myocardial infarction by transthoracic and transesophageal echocardiography.

The sensitivity of transthoracic echocardiography to visualize the structural abnormality of papillary muscle rupture (PMR) after acute myocardial infarction can be anticipated to average about 50%; therefore, we evaluated five patients exhibiting the condition with both transthoracic and transesophageal echocardiography. The use of the two imaging techniques resulted in the fact that no instance of PMR was missed. Using transthoracic echocardiography in two patients and transesophageal echocardiography in four, the ruptured papillary muscle was visualized directly. Mitral insufficiency as an indirect sign was observed in all patients. In one patient the papillary muscle rupture developed in a mitral valve previously affected by endocarditis. All patients underwent mitral valve replacement and coronary artery bypass grafting. The diagnosis was confirmed at surgery in all patients. Four patients died in hospital, the fifth 5 months later. We recommended that transesophageal echocardiography be performed in patients with suspected PMR if transthoracic echocardiography does not provide an unequivocal diagnosis.

Prognostic significance of vegetations detected by two-dimensional echocardiography in infective endocarditis.

Although 2DE is considered the most sensitive method for detecting vegetations in infective endocarditis, the independent clinical significance of these vegetations continues to be debated. To further examine this, we identified 74 patients who were diagnosed as having infective endocarditis over a 54-month period. The 50 patients who underwent 2DE examination form the basis of this report. Definite vegetations were present in 21 (42%) patients and measured 1.2 +/- 0.2 cm2. The vegetation was localized to the aortic valve in 10 patients, the mitral valve in eight, and the tricuspid valve in three. A major complication, defined as death, new-onset congestive heart failure, major arterial embolus, or valve surgery occurred in 86% of the vegetative endocarditis patients compared to 62% of those without vegetations. Among those patients with vegetations, death occurred in 24%, heart failure in 38%, arterial embolus in 48%, and surgery in 43%. This compared to 7%, 21%, 21%, and 24%, respectively, in those patients without vegetations. These data support the concept that 2DE detection of a vegetation defines a high-risk subgroup of patients with infective endocarditis in whom careful monitoring and aggressive management are warranted.